Alexandra Hawkey

ORCID: 0000-0003-0851-9117 · 8 papers in corpus · active 2021-2025

Study types

  • article 3
  • preprint 3
  • other 2

Condition tags

  • endometriosis 7
  • chronic_pelvic_pain 2
  • dysmenorrhea 1
  • mesh:D004715 1
  • adenomyosis 1
  • mesh:D004412 1
other 2025
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2024.12.019

STUDY OBJECTIVE: To explore menstrual cycle symptoms, information sources, and menstrual health literacy in young women (age 13-25) and those who menstruate in Aotearoa New Zealand DESIGN AND SETTING: A cross-sectional online survey in Aote…

other 2023
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare11222945

(1) Objectives: This paper presents a scoping review of global evidence relating to interventions (i.e., policies, practices, guidelines, and legislation) aimed at supporting women to manage menstruation, menstrual disorders, and menopause …

preprint 2023
·doi:10.21203/rs.3.rs-2783391/v1
article 2023
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina59091655

Background and Objectives: Endometriosis causes significant personal and societal burden. Despite this, research funding lags behind other chronic conditions. Determining where to prioritise these limited funds is therefore vital. Research …

article 2022
·doi:10.1177/09593535221083846

Chronic pelvic pain (CPP) in women is a term that encompasses a range of conditions, including endometriosis, vulvodynia, painful bladder syndrome and adenomyosis. Given the impact on penetrative sex, fertility and potentially motherhood, C…

article 2022
JMIR formative research ·doi:10.2196/40837

BACKGROUND: Endometriosis, which affects 1 in 10 people assigned female at birth, is a chronic systemic inflammatory disease with a high symptom burden and adverse socioemotional impacts. There is a need for an accessible, cost-effective, a…

preprint 2022
·doi:10.2196/preprints.40837

BACKGROUND Background: Endometriosis, affecting 1 in 10 people assigned female at birth, is a chronic systemic inflammatory disease, with high symptom burden and adverse socio-emotional impacts. There is a need for an accessible, cost-effe…

preprint 2021
·doi:10.21203/rs.3.rs-289745/v1